0.5501
price down icon15.37%   -0.0999
 
loading
前日終値:
$0.65
開ける:
$0.65
24時間の取引高:
323.90K
Relative Volume:
3.77
時価総額:
$4.78M
収益:
-
当期純損益:
$-33.44M
株価収益率:
-0.0343
EPS:
-16.0242
ネットキャッシュフロー:
$-28.30M
1週間 パフォーマンス:
-36.03%
1か月 パフォーマンス:
-31.24%
6か月 パフォーマンス:
-69.27%
1年 パフォーマンス:
-85.56%
1日の値動き範囲:
Value
$0.5501
$0.65
1週間の範囲:
Value
$0.5501
$0.89
52週間の値動き範囲:
Value
$0.5501
$10.79

Nucana Plc Adr Stock (NCNA) Company Profile

Name
名前
Nucana Plc Adr
Name
セクター
Healthcare (1154)
Name
電話
-
Name
住所
-
Name
職員
22
Name
Twitter
@NuCana_news
Name
次回の収益日
2024-11-14
Name
最新のSEC提出書
Name
NCNA's Discussions on Twitter

NCNA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NCNA
Nucana Plc Adr
0.5501 4.78M 0 -33.44M -28.30M -16.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-30 ダウングレード William Blair Outperform → Mkt Perform
2022-03-03 ダウングレード Cowen Outperform → Market Perform
2020-10-22 開始されました Truist Buy
2020-07-24 開始されました Oppenheimer Outperform
2019-08-19 開始されました H.C. Wainwright Buy
2018-10-19 開始されました Piper Jaffray Overweight
2017-10-23 開始されました Citigroup Buy
2017-10-23 開始されました Jefferies Buy
2017-10-23 開始されました William Blair Outperform
すべてを表示

Nucana Plc Adr (NCNA) 最新ニュース

pulisher
Apr 25, 2025

NCNA’s Stock Journey: What Investors Need to Know About NuCana plc ADR’s Performance - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Do investors need to be concerned about Cadiz Inc (CDZI)? - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Natera Inc (NTRA) deserves closer scrutiny - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Weave Communications Inc (WEAV) produces promising results - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Investing in NuCana plc ADR (NCNA) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

Post-Trade Analysis: NuCana plc ADR (NCNA) Slides -26.97, Closing at 0.65 - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Closing Bell Recap: Yxt.Com Group Holding Ltd. ADR (YXT) Ends at 0.56, Reflecting a -14.42 Downturn - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

In the Green: Gogoro Inc (GGR) Closes at 0.26, Up/Down 0.08 from Previous Day - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Daily Market Movement: Tivic Health Systems Inc (TIVC) Sees a 1.88 Increase, Closing at 7.04 - DWinneX

Apr 25, 2025
pulisher
Apr 09, 2025

RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Barchart.com

Apr 09, 2025
pulisher
Mar 12, 2025

Stock Update - Investorsobserver

Mar 12, 2025
pulisher
Nov 25, 2024

NuCana Reports Strong Phase 2 Data: 75% Disease Control in Melanoma Trial, Lower Q3 Loss - StockTitan

Nov 25, 2024
pulisher
Sep 27, 2024

Get in on NuCana plc ADR’s (NCNA) buy-in window today! - SETE News

Sep 27, 2024
pulisher
Sep 26, 2024

NuCana plc ADR Inc. (NCNA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Sep 26, 2024
pulisher
Sep 19, 2024

Daily Market Movement: NuCana plc ADR (NCNA) Sees a -7.03 Decrease, Closing at 3.44 - The Dwinnex

Sep 19, 2024
pulisher
Sep 17, 2024

NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance

Sep 17, 2024
pulisher
Sep 03, 2024

Oppenheimer slashes NuCana stock target, remains Outperform on optimism for upcoming trials - Investing.com

Sep 03, 2024
pulisher
Aug 29, 2024

NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments - TipRanks

Aug 29, 2024
pulisher
Jul 22, 2024

NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com

Jul 22, 2024
pulisher
Mar 27, 2024

NuCana plc Announces Reverse ADS Split - TipRanks

Mar 27, 2024
pulisher
Jan 03, 2024

NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha

Jan 03, 2024
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Jun 01, 2020

Will NuCana Continue to Surge Higher? - Nasdaq

Jun 01, 2020
pulisher
Sep 29, 2017

NCNA Stock Price and Chart — NASDAQ:NCNA - TradingView

Sep 29, 2017
pulisher
Sep 24, 2017

NuCana PLC Stock Price Today | NASDAQ: NCNA Live - Investing.com

Sep 24, 2017

Nucana Plc Adr (NCNA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
大文字化:     |  ボリューム (24 時間):